NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.
Brain Pathol
; 31(3): e12957, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-34043263
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoantibodies
/
Dermatomyositis
/
Neoplasms
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Brain Pathol
Journal subject:
CEREBRO
/
PATOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Suiza